Upload
biogenist
View
214
Download
0
Embed Size (px)
Citation preview
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
1/58
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
2/58
.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
3/58
.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
4/58
.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
5/58
Company IntroductionBiogenist (Pvt) Ltd started its operation in the year 2004.
It is a part of a group of companies engaged in diversified businesses.
Our initial focus is on the specialty of Obs / Gynee particularly Infertility
Management.
Biogenist has also entered into the Branded Generic Segment with the aim ofproviding effective & economical medicines for the entire community
.
.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
6/58
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
7/58
Vision
By 2016 Biogenist will be known to
the Practicing Gynecologists as a
company caring the entire basichealthcare needs of a common
person.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
8/58
All Infertility Centers of Pakistan Lahore Institute of Fertility & Endocrinology (LIFE) Lahore
Australian Concept Infertility Medical Center - Karachi
Baqai Institute of Reproductive Sciences (BIRDS) Karachi
Sind Institute of Reproductive Medicine (SIRM) - Karachi
Islamabad Clinic Serving Infertile Couples (Pvt) Ltd - Islamabad
Infertility Services (Pvt) Ltd - Islamabad
Gynecological Advisory Services - Islamabad
Aga Khan University Hospital
Armed Forces Institution of Pakistan
Practicing Gynecologists
.
Our Working Spectrum
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
9/58.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
10/58
Biogenist Pharma
Chief Executive
Officer
. 1
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
11/58. 1
THANK YOU
Biogenist Pharma (Pvt) Ltd
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
12/58
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
13/58
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
14/58
. 14
Infertility is a very common condition affectingapproximately 13-14% of couples in the reproductive
age group. Although this prevalence has remained stable over the
last few years, the demand for infertility services hasincreased substantially.
This increase is due primarily to the Baby Boomgeneration entering into the reproductive age group ata time of highly publicized technological advances.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
15/58
. 15
Definition of Infertility & ART
Common causes of infertility
Who is eligible for ART
Methodology of ovulation induction Improving SPA
Other techniques
Counseling couple Failure rate
Cost effectiveness
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
16/58
. 16
Infertility is defined classically as the inability to
conceive after 1 year of unprotected intercourse.This definition is based on the cumulativeprobability of pregnancy:
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
17/58
. 17
Month Monthly Probability Cumulative Probability
1 0.2 0.20
2 0.2 0.36
3 0.2 0.49
4 0.2 0.595 0.2 0.67
6 0.2 0.74
7 0.2 0.79
8 0.2 0.83
9 0.2 0.8610 0.2 0.89
11 0.2 0.91
12 0.2 0.93
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
18/58
. 18
ART refers to all techniques involvingdirect retrieval of oocytes from theovary
ART procedures include IVF, GIFT,ZIFT, and ICSI.
The simplest ART procedure, IVF hasbeen around for over 20 years and is
perhaps the most commonlyrecognized ART of all procedures.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
19/58
. 19
Causes of Infertility
Cause Couples Women
Male 35% N/A
Ovulatory 15% 40%
Tubal 35% 40%
Unexplained 10% 10%
Other 5% 10%
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
20/58
. 20
Female factors
Cervical factor
Ovulatory factor (PCOs)
Uterine factor (endometriosis)
Pelvic factor
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
21/58
. 21
Polycystic Ovarian Syndrome (PCOS)Also known as Stein-Leventhal syndrome
Also known as hyperandrogenic chronic anovulation is a benign
disorder that commonly results in infertility.PCOS is characterized by irregular ovulation and menses, obesity,insulin resistance, acne, and hirsutism.Most women with PCOS also have ovaries filled with multiplebenign cysts.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
22/58
. 22
How does PCOS contribute to Infertility?
Impaired fertility is a prominent feature of PCOS.
This is believed to result from elevated insulin levels that
stimulate excess androgen production by the ovaries.
The androgens cause premature follicular wasting whichcauses inconsistent or absent ovulation, which is
associated with infertility.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
23/58
. 23
Symptoms
Irregular or absent periods
Lack of ovulation Weight gain Hirsutism (excessive hair growth) Insulin resistance Acne Male-pattern balding
Multiple small ovarian cysts-these may be seen by an ultrasoundexamination
Ancthosis nigrans (darkening of the skin at the nape of the neck andunder the arms and breasts).
http://images.google.com.pk/imgres?imgurl=http://2.bp.blogspot.com/_B9CmlJEV37o/SXazrxkC7RI/AAAAAAAAAEc/CfB5wHruscg/s320/05.jpg&imgrefurl=http://yogaforobesity.blogspot.com/2009/01/pcod-disease-that-worries-woman.html&usg=__cOGyQmck6zIsf1y-q5GZx84YDEs=&h=275&w=312&sz=19&hl=en&start=1&um=1&itbs=1&tbnid=8_BKaDuoaHTrRM:&tbnh=103&tbnw=117&prev=/images?q=PCOD&um=1&hl=en&sa=G&tbs=isch:18/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
24/58
. 24
Diagnosis
:Blood Work/Hormonal Testing:
Laboratory testing is important for diagnosis but it is
crucial to look at multiple values collectively.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
25/58
. 25
Diagnosis:
3. Ultrasound:
Ultrasound of the pelvis is typically performed when the
clinician suspects PCOS.
If >10 cysts are found in either ovary that are less than10mm, this meets the ultrasound criteria for PCOS.Furthermore, polycystic ovaries are typically 1.5 to 3 timesthe normal size.
Just the presence of polycystic ovaries, without symptomsand/or consistent blood work, does not confirm a diagnosisof PCOS.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
26/58
. 26
Treatment
Weight Loss, Progestins, Oral Contraceptives,
Anti-Androgens, GnRH agonists, Fertility drugs,
Surgical therapy:
a) Ovarian wedge resection b) Laparoscopic ovarian drilling
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
27/58
. 27
Endometriosis
Endometriosis can be defined as a nonmalignantdisorder in which functioning endometrial tissue ispresent outside the uterus.
The incidence of this disease ranges from 10-15% inwomen between the ages of 25 and 44 who areactively menstruating, but it also occurs in teenagers.
It is estimated that 25-50% of infertile women havethis disease.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
28/58
Endometriosis
. 28
The incidence is higher in first degree relatives of
women with endometriosis, which suggests that
heredity may play a role.
In addition, there is also a higher prevalence of the
disease in women who delay childbearing or who are
of Asian descent.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
29/58
. 29
Causes and Symptoms
The cause of endometriosis is unknown, however there areseveral theories.
The first theory is known as retrograde menstruation, or themovement of sloughed endometrial tissue back through thefallopian tubes and into the abdominal cavity. This tissue canthen attach itself to various internal organs or tissues outside ofthe uterus.
Immune system dysfunction. It is believed that certain womenmay develop endometriosis due to deficiencies in their immunesystem.
Endometriosis
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
30/58
. 30
In women without endometriosis, the immunesystem destroys any ectopic implants that maydevelop. However, in women with endometriosis,there is an altered immune response and the body isunable to destroy the growth of the implants.
Furthermore, some scientists believe thatendometriosis is an autoimmune disorder. Thismeans that the body makes antibodies toendometrial cells. These antibodies may destroy the
healthy endometrium found in the uterus, but areineffective in destroying ectopic implants.
Endometriosis
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
31/58
. 31
Symptoms
Pelvic pain and cramping before and duringperiods
Pain during intercourse
Inability to conceive
Fatigue
Painful urination during periods
Gastrointestinal symptoms such as diarrhea,constipation, and nausea
Endometriosis
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
32/58
. 32
There are other medical conditions that have similarsymptoms and should be considered prior to making adiagnosis of endometriosis. Conditions that may causegeneralized pelvic pain include:
Pelvic inflammatory disease (PID) Pelvic adhesions
Neoplasms (cancers), both benign or malignant
Ovarian torsion
Sexual or physical abuse
Other causes that are not gynecologic in nature
Endometriosis
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
33/58
. 33
How does endometriosis contribute toinfertility?
The cause of infertility is believed to result from the
scarring and adhesions that form in the reproductivetract as a result of inflammation.
Scar tissue and adhesions may reduce fertility by either
obstructing or distorting the shape of the fallopian
tubes, which in turn impedes the passage of sperm to
the egg.
Endometriosis
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
34/58
. 34
In the event that sperm do reach the egg, they
may encounter a hostile environment
unfavorable to fertilization.
Finally, scarring from endometriosis may
obstruct the fallopian tubes so that if an egg is
fertilized, it may be unable to travel to the uterus
for implantation.
Endometriosis
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
35/58
. 35
Diagnosis
One of two techniques may be used to confirm thediagnosis of endometriosis. Both procedures involvevisualization of the pelvic cavity in order to confirm
the presence or absence of ectopic implants. laparoscopy
laparotomy
If there are any suspected ectopic implants, they arebiopsied in order to determine the presence of
endometrial cells.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
36/58
. 36
Women with tubal diseases
Unexplained infertility
Endometriosis
Immunologic causes for infertility
Women with premature ovarian failure
Individuals with male factor infertility (e.g.,abnormalities in sperm production, function
or transport or prior vasectomy)
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
37/58
. 37
Basically, this term refers to the use of medications
to stimulate your body to produce one or more
eggs.
Ovulation induction can be as simple as taking a
daily pill or more complicated, like injecting
fertility medications and seeing your specialist
daily for necessary monitoring. The simplest form
of ovulation induction involves taking clomiphene.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
38/58
. 38
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
39/58
. 39
More potent medications, known as the gonadotropins,are available for more intensive ovulation induction.
Gonadotropins are injectable medications that are madeup of a combination of follicle stimulating hormone (FSH)and luteinizing hormone (LH) or just FSH alone.
These hormones can be very helpful in getting a woman to
produce and release her eggs.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
40/58
. 40
The success of ovulation induction in achieving a
pregnancy is highly variable. It depends on the
diagnosis, age, the medication being used, and
numerous other factors.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
41/58
. 41
Sperm penetration assay (SPA) is a multi-step laboratory
test that offers a biological assessment of human spermfertilizing ability.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
42/58
. 42
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
43/58
. 43
ZIFT
GIFT
TEST
POST
ICSI
TESE
MESA
PGD
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
44/58
. 44
ZIFT
Zygote Intrafallopian Transfer. ZIFT may berecommended if the husband has severe male fertility factor or if there has been difficulty confirming
fertilization with past procedures. ZIFT has theadvantages of allowing fertilization to be confirmedand it has demonstrated higher success rates thanIVF when used for the appropriate indications.
One disadvantage with ZIFT is that the transfer of the
zygote must be performed through a laparoscope.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
45/58
. 45
GIFT
Gamete intrafallopian transfer was developing in 1984 as avariation of in vitro fertilization (IVF).
Gift is recommended when
unexplained infertility
infertility due to immunological factors
endometriosis
selected cases of male infertility
Tubal infertility
A requirement for the procedure is that the female partnerhaving at least one open (patent) fallopian tube.
http://images.google.com.pk/imgres?imgurl=http://www.netterimages.com/images/vpv/000/000/004/4082-0550x0475.jpg&imgrefurl=http://www.netterimages.com/image/4082.htm&usg=__ldH7Cz99ssa1MptPlIhI7YA9F8k=&h=550&w=475&sz=105&hl=en&start=176&um=1&itbs=1&tbnid=r2cVh2qXe7OqxM:&tbnh=133&tbnw=115&prev=/images?q=ZIFT&start=160&um=1&hl=en&sa=N&ndsp=20&tbs=isch:1http://images.google.com.pk/imgres?imgurl=http://www.netterimages.com/images/vpv/000/000/004/4082-0550x0475.jpg&imgrefurl=http://www.netterimages.com/image/4082.htm&usg=__ldH7Cz99ssa1MptPlIhI7YA9F8k=&h=550&w=475&sz=105&hl=en&start=176&um=1&itbs=1&tbnid=r2cVh2qXe7OqxM:&tbnh=133&tbnw=115&prev=/images?q=ZIFT&start=160&um=1&hl=en&sa=N&ndsp=20&tbs=isch:18/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
46/58
. 46
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
47/58
. 47
ICSI
Intracytoplasmic sperm injection, or ICSI, was
developed to treat couples who previously had a verypoor probability of achieving fertilization due to the
male partner's extremely low numbers of viable
sperm.
This treatment, when combined with in vitrofertilization, allows these couples a more favorable
probability of achieving conception.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
48/58
. 48
ICSI
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
49/58
. 49
TESE
Testicular Sperm Extraction
MESA Microsurgical Epididymal Sperm Aspiration
What is Preimplantation Genetic Diagnosis?
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
50/58
. 50
PGD
Preimplantation Genetic Diagnosis
The Preimplantation Genetic Diagnosis (PGD) is a new method ofPrenatal Diagnosis. The aim of this study is to increase the chances of
having a healthy baby and therefore, avoiding the chances of
transmitting a genetic or hereditary disease. In order to perform the
diagnosis we use high technology with each embryo
http://www.geneticsandsociety.org/img/original/pgd2.jpg8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
51/58
What is Preimplantation Genetic Diagnosis?
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
52/58
. 52
PGD
Preimplantation Genetic Diagnosis
Preimplantation Genetic Diagnosis is recommended
for those couples who are carriers or suffer from
genetic or chromosomal diseases that aretransmissible to their offspring. It is also
recommended for women of an advanced age, for
women who have had repeated miscarriages, for
patients undergoing fertility treatments who have failed several times to conceive through In Vitro
Fertilization and finally for those couples who produce
embryos with morphological alterations
http://www.geneticsandsociety.org/img/original/pgd2.jpg8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
53/58
. 53
The use of skills that enable a client to recognize andidentify his (sic) own problems, and the ability to helpclient find his own solution or resolution.
The Human Fertilization and Embryology Authority
(HFEA) state in their code of practice that three sortsof counseling must be available at licensed treatmentcenter. These are:
Support counseling
Implications counseling Therapeutic counseling
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
54/58
. 54
One of the first questions that most people ask is "what isthe chance for success?" The best estimate is that thebirth of a live baby occurs in approximately 15-25% of
women in whom embryos are transferred into the uterus. The 1998 nationwide live birth rate as reported in the IVF-
ET Registry, was 24.9%.
The corresponding rate for 1989 was 14%.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
55/58
. 55
Success varies with many factors, including the numberof embryos that are transferred.
If one embryo is transferred, there is approximately a
7% chance of successful implantation; with twoembryos, the success rate increases to 18%.
The rate peaks with the transfer of three to fourembryos. Presently, the collection of oocytes,fertilization, and early embryo growth are accomplished
with a high degree of efficiency.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
56/58
. 56
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
57/58
. 57
Twins occur in about 25% of ART pregnancies versus 1-2%of spontaneous pregnancies. The risk of more than atwin pregnancy is less than 5%.
To put these figures into perspective, studies have shownthat the rate of pregnancy in couples with proven fertilityin the past is approximately 20% per cycle. Therefore,although a figure of 15-25% may sound low, it is equal toor greater than the chance that a fertile couple will
conceive in any given cycle.
8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF
58/58
We are all angels with only one wing.
We can only fly while embracing each other.
- Luciano D. Crecenzo
Thank you!